Report Categories
View AllRecent Articles
View All
TTEC Holdings TTEC Q1 2026 Earnings Miss EPS 015 vs 024 Expected
Geron Corporation GERN Q1 2026 Earnings Why the Beat Matters
Proto Labs PRLB Q1 2026 Earnings Surprise EPS 054 Up Significant
Jury Dismisses All Claims in Elon Musks Lawsuit Against OpenAI CEO Sam Altman
National NRUC at 2395 Buy Sell or Hold 20260518
MainStreet MNSBP Q1 2026 Earnings Why the Beat Matters
TOYO Co TOYO Stock Jumps 1319 Approaching 1506 20260518
Should You Sell Qiagen QGEN After 087 Drop 20260515
SP 500 Gains as Healthcare and Tech Outperform Communication Services Lags
Nuclear Verdict Alert 50M Jury Award Against Texas Trucking Company Raises Industry Concerns
Quad Foreign Ministers Meet in New Delhi to Strengthen IndoPacific Cooperation Amid Geopolitical Shifts
Restaurants PayWhatYouWant Model Highlights Challenges in Dining Industry
SpaceX IPO Speculation Fuels Surge in SpaceRelated Stocks and ETFs
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister
MIAX Q1 2026 Earnings EPS Surpasses Estimates by 98 Amid Stable Operations
CV Q1 2026 Earnings EPS Misses Estimates as Company Reports Wider Loss
RCUS Q1 2026 Earnings EPS Miss Highlights Ongoing RD Investment Challenges
Citi Trends CTRN Q1 2026 Earnings EPS Surges Past Estimates Shares Gain 253
UFCS Q1 2026 Earnings Strong EPS Beat Reflects Improved Underwriting Performance
ALB Q1 2026 Earnings Massive EPS Beat Surprises Markets
Hooker Furnishings HOFT Climbs 158 Approaching Key Resistance at 1413
TEN Holdings Inc XHLD Holds Steady Near Support Amid Low Volatility
NetSTREIT NTST Slides Slightly as Support Levels Come into Focus
Pure Cycle PCYO Edges Lower Amid Quiet Trading Key Support Levels in Focus
Pedevco Corp PED Rallies 431 as Shares Test Resistance Near 1550
Labor Market Update Key Findings from the Latest Jobs Report
TrumpXi Summit Concludes Amid Celebration But Tangible Trade Deals Remain Limited
Affiliated MGRE Q1 2026 Earnings Beat Revenue NA EPS 823
IndiaUAE Energy Push Offers Partial Relief but Global Realignments Pose Persistent Risks
Processa Pharmaceuticals PCSA Q4 2025 Disappoints EPS 257 Below 153 Views